Wyeth Modifies Premarin Warnings Slightly
This article was originally published in The Pink Sheet Daily
Executive Summary
Data from estrogen-alone and estrogen-plus-progestin substudies of the Women’s Health Initiative now included in black box for Premarin products.
You may also be interested in...
Wyeth Wins Round One Of 5,000 In Hormone Therapy Suits
Research findings about breast cancer risk from Premarin are mixed, Wyeth maintains.
Wyeth Wins Round One Of 5,000 In Hormone Therapy Suits
Research findings about breast cancer risk from Premarin are mixed, Wyeth maintains.
Estrogen Use Alone Does Not Increase Breast Cancer Risk, JAMA Analysis Finds
Women’s Health Initiative data analysis shows increase in frequency of mammography screenings requiring short-term follow-up.